Welcome to Charlesson
Charlesson is an Oklahoma-based pharmaceutical company located in the Presbyterian Health Foundation's Research Park. Charlesson is actively engaged in the development of therapeutics for treating debilitating
ophthalmic diseases. Our product pipeline includes pharmaceutical treatments for Age-Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammation, Angiogenesis, and systemic diabetes.
Charlesson's lead candidate, CLT-003, is for the treatment of Diabetic Macular Edema, for which there is no therapeutic
currently approved.
In addition to drug development, Charlesson also offers preclinical contract research with unique capabilities for ophthalmic testing such as:
- Angiogenesis Models
- Diabetic Models
- Macular Degeneration Models
- Retinal Degeneration Models
- in-vitro Studies
- Various Assays
Charlesson Would Like to Thank the Following for Their Generous Support:
